NCT03222557

Brief Summary

This is a prospective, randomized, sham-controlled, superiority trial that aimed to investigate the efficacy of electroacupuncture (EA) in reducing the duration of postoperative ileus and hospital stay after laparoscopic total mesorectal excision or abdominoperineal resection for rectal cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 19, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

October 6, 2017

Status Verified

October 1, 2017

Enrollment Period

2.1 years

First QC Date

July 14, 2017

Last Update Submit

October 5, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • GI-2 recovery

    A composite assessment that measured upper (first tolerance of solid food) and lower (first bowel movement) GI tract recovery, with time to achieve GI-2 recovery based on the last event to occur

    Up to 10 days

Secondary Outcomes (6)

  • Time of first passing flatus

    Up to 10 days

  • Length of hospital stay

    Up to 1 month

  • Pain scores on the first 3 postoperative days

    Up to postoperative day 3

  • Postoperative analgesic requirement

    Up to 1 month

  • Short-term morbidity

    Up to 1 month

  • +1 more secondary outcomes

Study Arms (2)

Electroacupuncture (EA)

EXPERIMENTAL

Bilateral acupoints relevant to the treatment of abdominal pain, abdominal distension, and constipation, including Zusanli (stomach meridian ST-36), Sanyinjiao (spleen meridian SP-6), Hegu (large intestine meridian LI-4), and Zhigou (triple energizer meridian TE-6), will be used. Electric stimulation at a frequency of 50 Hz will be employed to the needles

Procedure: ElectroacupunctureDevice: Electroacupuncture

Sham Acupuncture (SA)

SHAM COMPARATOR

Sterile blunt-tip needles will be placed (without skin penetration) 20 mm away from the acupoints. The needle will be first inserted through a sterile plastic tube mounted on a foam block, and then pressed on the skin. The foam block compresses to give the impression that the needle is penetrating the skin, thus providing a SA effect. 'Pseudostimulation' will be given by deliberately connecting the needle to the incorrect output socket of the electroacupuncture device, thus there will be no flow of electric current.

Procedure: Sham AcupunctureDevice: Sham Acupuncture

Interventions

Refer to arm description

Also known as: EA
Electroacupuncture (EA)

Refer to arm description

Also known as: SA
Sham Acupuncture (SA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive patients (aged between 18 and 80) with mid/low rectal cancer (adenocarcinoma in the rectum of which the lowest margin of the tumor is located within 12 cm of the anal verge as measured by rigid sigmoidoscopy) undergoing laparoscopic sphincter-preserving TME or APR without the need of conversion
  • American Society of Anesthesiologists grading I-III
  • Informed consent available

You may not qualify if:

  • Patients with previous experience of acupuncture
  • Those undergoing simultaneous laparoscopic resection of rectal cancer and other coexisting intraabdominal diseases
  • Those undergoing laparoscopic resection of rectal cancer with en bloc resection of surrounding organs
  • Those who developed intraoperative problems or complications (e.g. bleeding, tumor perforation) that required conversion
  • Those undergoing emergency surgery
  • Those with previous history of midline laparotomy
  • Those with evidence of peritoneal carcinomatosis
  • Those who are expected to receive epidural anesthesia or analgesia
  • Those with cardiac pacemaker
  • Those who are pregnant
  • Those who are allergic to the acupuncture needles

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Rectal Neoplasms

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Simon SM Ng, MD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The acupuncturist is the only individual who is aware of the treatment allocation; the patients randomized to the EA/SA groups and the outcome assessor are blinded to the treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

July 14, 2017

First Posted

July 19, 2017

Study Start

November 1, 2017

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

October 6, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations